Literature DB >> 3757562

Clinical features of lung cancers discovered as a postmortem "surprise".

M J McFarlane, A R Feinstein, C K Wells.   

Abstract

Despite improved modern diagnostic techniques, many patients with primary lung cancer escape detection of their disease during life. In a review of postmortem records at a university hospital, 28 percent of 153 primary lung cancers found at necropsy had not been diagnosed while the patient was alive. The male/female ratio was 1.3 in this undetected group, compared with 2.3 in the detected group. The main clinical features that seemed to lead to nondiagnosis were a terminal clinical state in patients who were too sick for further diagnostic searches, the absence of suggestive primary symptoms, a chest x-ray film interpreted as not showing primary lung cancer, and the absence of cigarette smoking. Among the patients with lung cancer at necropsy, the proportion of nonsmokers was higher in the previously undiagnosed group than in the group with antemortem diagnoses, even when patients were stratified for primary symptoms. The findings suggest the need for diagnostic alertness to the possibility that curable lung cancer can occur in patients who have a positive chest-film lesion but who are nonsmokers and who lack typical symptoms.

Entities:  

Mesh:

Year:  1986        PMID: 3757562     DOI: 10.1378/chest.90.4.520

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

Review 1.  Lung cancer screening.

Authors:  Antonio Gutierrez; Robert Suh; Fereidoun Abtin; Scott Genshaft; Kathleen Brown
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

Review 2.  Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial.

Authors:  Denise R Aberle; Fereidoun Abtin; Kathleen Brown
Journal:  J Clin Oncol       Date:  2013-02-11       Impact factor: 44.544

3.  Angiogenin and vascular endothelial growth factor expression in lungs of lung cancer patients.

Authors:  Ales Rozman; Mira Silar; Mitja Kosnik
Journal:  Radiol Oncol       Date:  2012-11-09       Impact factor: 2.991

4.  Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From Hungary.

Authors:  Krisztina Bogos; Zoltán Kiss; Gabriella Gálffy; Lilla Tamási; Gyula Ostoros; Veronika Müller; László Urbán; Nóra Bittner; Veronika Sárosi; Aladár Vastag; Zoltán Polányi; Zsófia Nagy-Erdei; Zoltán Vokó; Balázs Nagy; Krisztián Horváth; György Rokszin; Zsolt Abonyi-Tóth; Judit Moldvay
Journal:  Front Oncol       Date:  2019-10-23       Impact factor: 6.244

5.  What is a reasonable cost to refute a preposterous hypothesis?

Authors:  A W Castleberry; F W Grannis
Journal:  Br J Cancer       Date:  2010-01-05       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.